• 1
    Bossley JC, Fleming L, Gupta A, Regamey N, Frith H, Oates T et al. Pediatric severe asthma is characterized by eosinophilia and remodelling without TH2 cytokines. J Allergy Clin Immunol 2012;129:97482.
  • 2
    Bush A. Phenotype specific treatment of asthma in childhood. Paediatr Respir Rev 2004;5:S93S101.
  • 3
    Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008;178:218224.
  • 4
    Nadif R, Siroux V, Oryszczyn MP, Ravault C, Pison C, Pin I et al. Epidemiological study on the Genetics and Environment of Asthma (EGEA). Heterogeneity of asthma according to blood inflammatory patterns. Thorax 2009;64:374380.
  • 5
    Wood LG, Baines KJ, Fu J, Scott HA, Gibson PG. The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma. Chest 2012;142:8693.
  • 6
    Bush A, Saglani S. Management of severe asthma in children. Lancet 2010;4:376.
  • 7
    Sharples J, Gupta A, Fleming L, Bossley JC, Bracken-King M, Hall P et al. Long-term effectiveness of a staged assessment for paediatric problematic severe asthma. ERJ 2012;40:264278.
  • 8
    Bracken M, Fleming L, Hall P, Van Stiphout N, Bossley C, Biggart E et al. The importance of nurse-led home visits in the assessment of children with problematic asthma. Arch Dis Child 2009;94:780784.
  • 9
    Payne DN, Qiu Y, Zhu J, Peachey L, Scallan M, Bush A et al. Airway inflammation in children with difficult asthma: relationships with airflow limitation and persistent symptoms. Thorax 2004;59:862869.
  • 10
    Stanojevic S, Wade A, Stocks J, Hankinson J, Coates AL, Pan H et al. Reference ranges for spirometry across all ages: a new approach. Am J Respir Crit Care Med 2008;177:253260.
  • 11
    Buchvald F, Baraldi E, Carraro S, Gaston B, De Jongste J, Pijnenburg MW et al. Measurements of exhaled nitric oxide in healthy subjects age 4–17 years. J Allergy Clin Immunol 2005;115:11301136.
  • 12
    Lex C, Payne DN, Zacharasiewicw A, Li AM, Wilson NM, Hansel TT et al. Sputum induction in children with difficult asthma: safety, feasibility, and inflammatory cell pattern. Pediatr Pulmonol 2005;39:318324.
  • 13
    Cai Y, Carty K, Henry RL, Gibson PG. Persistence of sputum eosinophilia in children with controlled asthma when compared with healthy children. Eur Respir J 1998;11:848853.
  • 14
    Orkin HS, Fisher ED, Look AT, Lux IVS, Ginsburg D, Nathan GD. Nathan and Oski's Hematology of Infancy and Childhood. Philadelphia; London: Saunders c2009 7th edn.
  • 15
    Lex C, Ferreira F, Zacharasiewicz A, Nicholson AG, Haslam PL, Wilson NM et al. Airway eosinophilia in children with severe asthma: predictive values of noninvasive tests. Am J Respir Crit Care Med 2006;174:12861291.
  • 16
    Hilliard TN, Regamey N, Shute JK, Nicholson AG, Alton EW, Bush A et al. Airway remodelling in children with cystic fibrosis. Thorax 2007;62:10741080.
  • 17
    Fitch PS, Brown V, Schock BC, Taylor R, Ennis M, Shields MD. Chronic cough in children: bronchoalveolar lavage findings. Eur Respir J 2000;16:11091114.
  • 18
    Banovcin P, Jesenak M, Michnova Z, Babusikova E, Nosal S, Mikler J et al. Factors attributable to the level of exhaled nitric oxide in asthmatic children. Eur J Med Res 2009;14:913.
  • 19
    Good JT Jr, Kolakowski CA, Groshong SD, Murphy JR, Martin RJ. Refractory asthma: importance of bronchoscopy to identify phenotypes and direct therapy. Chest 2012;141:599606.
  • 20
    Petsky HL, Cates CJ, Lasserson TJ, Li AM, Turner C, Kynaston JA et al. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils). Thorax 2012;67:199208.
  • 21
    Spector SL, Tan RA. Is a single blood eosinophil count a reliable marker for “eosinophilic asthma?”. J Asthma 2012;49:807810.